What Analytical Purity Means
Purity claims on research peptide labeling are shorthand for a more complex analytical picture. This article explains how purity is typically calculated from chromatographic data, the difference between area-percent purity and other measures, and the factors that can make purity figures misleading if taken out of context.
Purity Is a Measurement, Not a Property
It is tempting to think of purity as an inherent, fixed property of a compound, but purity is more accurately described as the output of a measurement process applied to a specific sample. Change the analytical method, the column, the mobile phase, or the detection wavelength, and the reported purity value can shift — sometimes meaningfully. Understanding purity means understanding the measurement behind the number, not just the number itself.
Area-Percent Purity via HPLC
The most common approach for peptides is reversed-phase HPLC with UV detection. A sample is injected onto a chromatographic column, and its components separate based on differing interactions with the column's stationary phase. Each eluting component produces a peak on the resulting chromatogram, and the area under each peak is roughly proportional to the quantity of that component present, assuming similar detector response.
Area-percent purity is calculated by dividing the area of the main (target) peak by the sum of all detected peak areas, then multiplying by 100. This method is widely used because it is relatively fast and does not require a separate quantitative reference standard for every impurity — but it carries an important caveat: it assumes all components absorb UV light at the detection wavelength to a similar degree. Impurities that absorb weakly at that wavelength can be under-represented, while the main peak can be over-represented, in the reported percentage.
Mass-Based and Orthogonal Confirmation
Because area-percent HPLC purity can have blind spots, more rigorous analytical programs pair it with an orthogonal method — commonly mass spectrometry — to confirm that the dominant peak is in fact the target molecule and to help characterize what any minor peaks represent (e.g., truncated sequences, oxidized variants, or synthesis-related byproducts common in solid-phase peptide synthesis).
Some laboratories also report content or assay values distinct from purity — for example, a mass-balance or reference-standard-based assay expressing how much of the target compound is present relative to the total sample weight, accounting for moisture, counter-ions, or residual solvents. Purity and content answer different questions, and a COA that reports only one should not be assumed to imply the other.
Why Method Validation Matters
A purity number is only as trustworthy as the method used to generate it. Analytical validation frameworks — such as ICH Q2(R2) for analytical procedure validation, and general chapters like USP <1225> covering validation of compendial procedures — describe how a laboratory demonstrates that a given method reliably and reproducibly measures what it is intended to measure, addressing characteristics such as specificity (can the method distinguish the target from impurities), linearity (does response scale predictably with concentration), precision (repeatability of results), and robustness (stability of results under small deliberate variations).
When a laboratory states that its purity method has been validated according to a recognized framework, it is making a claim about the reliability of the measurement process — not asserting that every sample tested will show a particular purity value. A research reader benefits from understanding this distinction when comparing COAs across suppliers or laboratories.
Common Sources of Impurity in Synthetic Peptides
Synthetic peptides are typically produced via solid-phase peptide synthesis (SPPS), a stepwise chemical process. Imperfect coupling or deprotection at any step can generate related-substance impurities such as deletion sequences (missing an amino acid), truncated sequences, or side-reaction products. Purification steps, commonly preparative HPLC, are used afterward to enrich the target sequence and separate it from these by-products, but complete elimination of every trace impurity is analytically and practically difficult, which is why purity is reported as a percentage rather than treated as an absolute binary.
Interpreting Purity Figures Responsibly
For a research setting, the most useful approach is to review the underlying chromatogram and method details rather than rely solely on a headline percentage, to check whether identity has been independently confirmed (see our companion article on reading a COA), and to consider purity data alongside lot-specific traceability information. None of this discussion addresses or implies suitability for human or animal use — all figures described here pertain strictly to laboratory analytical characterization.